Polaris Capital Management, LLC United Therapeutics Corp Transaction History

Polaris Capital Management, LLC

$1.67 Billion
Q2 2024

A detailed history of Polaris Capital Management, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Polaris Capital Management, LLC holds 148,550 shares of UTHR stock, worth $53.2 Million. This represents 2.84% of its overall portfolio holdings.

Number of Shares

148,550

Previous 129,950 14.31%

Holding current value

$53.2 Million

Previous $29.9 Million 58.52%

% of portfolio

2.84%

Previous 1.68%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	BUY	$228.26 - $319.04 $4.25 Million - $5.93 Million	18,600 Added 14.31%	148,550 $47.3 Million
Q1 2024 Apr 24, 2024	SELL	$210.76 - $249.51 $2.66 Million - $3.14 Million	-12,600 Reduced 8.84%	129,950 $29.9 Million
Q4 2023 Feb 07, 2024	BUY	$214.88 - $256.94 $1.72 Million - $2.06 Million	8,000 Added 5.95%	142,550 $31.3 Million
Q3 2023 Oct 30, 2023	SELL	$211.82 - $248.24 $12.4 Million - $14.5 Million	-58,600 Reduced 30.34%	134,550 $30.4 Million
Q2 2023 Jul 31, 2023	SELL	$205.19 - $232.99 $205,190 - $232,990	-1,000 Reduced 0.52%	193,150 $42.6 Million
Q1 2023 Apr 28, 2023	SELL	$212.99 - $276.17 $27.1 Million - $35.1 Million	-127,250 Reduced 39.59%	194,150 $43.5 Million
Q4 2022 Feb 09, 2023	SELL	$205.95 - $280.43 $4.22 Million - $5.75 Million	-20,500 Reduced 6.0%	321,400 $89.4 Million
Q3 2022 Nov 10, 2022	SELL	$203.3 - $244.17 $1.89 Million - $2.27 Million	-9,300 Reduced 2.65%	341,900 $71.6 Million
Q2 2022 Aug 12, 2022	BUY	$174.81 - $241.14 $58.8 Million - $81.1 Million	336,439 Added 2279.24%	351,200 $82.8 Million
Q2 2022 Aug 10, 2022	SELL	$174.81 - $241.14 $59.3 Million - $81.9 Million	-339,439 Reduced 95.83%	14,761 $1.2 Million
Q1 2022 May 11, 2022	SELL	$166.16 - $213.96 $3.42 Million - $4.41 Million	-20,600 Reduced 5.5%	354,200 $63.5 Million
Q4 2021 Feb 01, 2022	SELL	$184.32 - $216.08 $1.12 Million - $1.32 Million	-6,100 Reduced 1.6%	374,800 $81 Million
Q3 2021 Nov 09, 2021	SELL	$179.86 - $214.88 $215,832 - $257,856	-1,200 Reduced 0.31%	380,900 $70.3 Million
Q2 2021 Aug 10, 2021	BUY	$170.47 - $211.93 $272,752 - $339,088	1,600 Added 0.42%	382,100 $68.6 Million
Q1 2021 May 11, 2021	BUY	$153.94 - $174.85 $58.6 Million - $66.5 Million	380,500 New	380,500 $72.2 Million

Others Institutions Holding UTHR

# of Institutions

619

Shares Held

45M

Call Options Held

368K

Put Options Held

410K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.3B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Polaris Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Polaris Capital Management, LLC with notifications on news.

Account

Polaris Capital Management, LLC United Therapeutics Corp Transaction History